These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. The embryonic type of SPP1 transcriptional regulation is re-activated in glioblastoma. Kijewska M; Kocyk M; Kloss M; Stepniak K; Korwek Z; Polakowska R; Dabrowski M; Gieryng A; Wojtas B; Ciechomska IA; Kaminska B Oncotarget; 2017 Mar; 8(10):16340-16355. PubMed ID: 28030801 [TBL] [Abstract][Full Text] [Related]
7. Side population in human glioblastoma is non-tumorigenic and characterizes brain endothelial cells. Golebiewska A; Bougnaud S; Stieber D; Brons NH; Vallar L; Hertel F; Klink B; Schröck E; Bjerkvig R; Niclou SP Brain; 2013 May; 136(Pt 5):1462-75. PubMed ID: 23460667 [TBL] [Abstract][Full Text] [Related]
8. Treatment with the PI3K inhibitor buparlisib (NVP-BKM120) suppresses the growth of established patient-derived GBM xenografts and prolongs survival in nude rats. Netland IA; Førde HE; Sleire L; Leiss L; Rahman MA; Skeie BS; Miletic H; Enger PØ; Goplen D J Neurooncol; 2016 Aug; 129(1):57-66. PubMed ID: 27283525 [TBL] [Abstract][Full Text] [Related]
9. PI3 kinase pathway regulated miRNome in glioblastoma: identification of miR-326 as a tumour suppressor miRNA. Nawaz Z; Patil V; Paul Y; Hegde AS; Arivazhagan A; Santosh V; Somasundaram K Mol Cancer; 2016 Nov; 15(1):74. PubMed ID: 27871300 [TBL] [Abstract][Full Text] [Related]
10. The angiogenic switch leads to a metabolic shift in human glioblastoma. Talasila KM; Røsland GV; Hagland HR; Eskilsson E; Flønes IH; Fritah S; Azuaje F; Atai N; Harter PN; Mittelbronn M; Andersen M; Joseph JV; Hossain JA; Vallar L; Noorden CJ; Niclou SP; Thorsen F; Tronstad KJ; Tzoulis C; Bjerkvig R; Miletic H Neuro Oncol; 2017 Mar; 19(3):383-393. PubMed ID: 27591677 [TBL] [Abstract][Full Text] [Related]
11. shRNA-mediated PPARα knockdown in human glioma stem cells reduces in vitro proliferation and inhibits orthotopic xenograft tumour growth. Haynes HR; Scott HL; Killick-Cole CL; Shaw G; Brend T; Hares KM; Redondo J; Kemp KC; Ballesteros LS; Herman A; Cordero-Llana O; Singleton WG; Mills F; Batstone T; Bulstrode H; Kauppinen RA; Wurdak H; Uney JB; Short SC; Wilkins A; Kurian KM J Pathol; 2019 Apr; 247(4):422-434. PubMed ID: 30565681 [TBL] [Abstract][Full Text] [Related]
12. An efficient method for derivation and propagation of glioblastoma cell lines that conserves the molecular profile of their original tumours. Fael Al-Mayhani TM; Ball SL; Zhao JW; Fawcett J; Ichimura K; Collins PV; Watts C J Neurosci Methods; 2009 Jan; 176(2):192-9. PubMed ID: 19215724 [TBL] [Abstract][Full Text] [Related]
13. [Activation of CXCR4 in human glioma stem cells promotes tumor angiogenesis]. Ping YF; Yao XH; Bian XW; Chen JH; Zhang R; Yi L; Zhou ZH Zhonghua Bing Li Xue Za Zhi; 2007 Mar; 36(3):179-83. PubMed ID: 17535685 [TBL] [Abstract][Full Text] [Related]
14. Cell line-based xenograft mouse model of paediatric glioma stem cells mirrors the clinical course of the patient. Larsson S; Wenger A; Dósa S; Sabel M; Kling T; Carén H Carcinogenesis; 2018 Oct; 39(10):1304-1309. PubMed ID: 29982329 [TBL] [Abstract][Full Text] [Related]
15. Detection of p53 mutations in proliferating vascular cells in glioblastoma multiforme. Kawasoe T; Takeshima H; Yamashita S; Mizuguchi S; Fukushima T; Yokogami K; Yamasaki K J Neurosurg; 2015 Feb; 122(2):317-23. PubMed ID: 25415071 [TBL] [Abstract][Full Text] [Related]
16. Side population is not necessary or sufficient for a cancer stem cell phenotype in glioblastoma multiforme. Broadley KW; Hunn MK; Farrand KJ; Price KM; Grasso C; Miller RJ; Hermans IF; McConnell MJ Stem Cells; 2011 Mar; 29(3):452-61. PubMed ID: 21425408 [TBL] [Abstract][Full Text] [Related]
17. Glioblastoma Exhibits Inter-Individual Heterogeneity of TSPO and LAT1 Expression in Neoplastic and Parenchymal Cells. Cai L; Kirchleitner SV; Zhao D; Li M; Tonn JC; Glass R; Kälin RE Int J Mol Sci; 2020 Jan; 21(2):. PubMed ID: 31963507 [TBL] [Abstract][Full Text] [Related]
18. Isolation of tumour stem-like cells from benign tumours. Xu Q; Yuan X; Tunici P; Liu G; Fan X; Xu M; Hu J; Hwang JY; Farkas DL; Black KL; Yu JS Br J Cancer; 2009 Jul; 101(2):303-11. PubMed ID: 19568241 [TBL] [Abstract][Full Text] [Related]
19. Atracurium Besylate and other neuromuscular blocking agents promote astroglial differentiation and deplete glioblastoma stem cells. Spina R; Voss DM; Asnaghi L; Sloan A; Bar EE Oncotarget; 2016 Jan; 7(1):459-72. PubMed ID: 26575950 [TBL] [Abstract][Full Text] [Related]
20. The gain-of-function GLI1 transcription factor TGLI1 enhances expression of VEGF-C and TEM7 to promote glioblastoma angiogenesis. Carpenter RL; Paw I; Zhu H; Sirkisoon S; Xing F; Watabe K; Debinski W; Lo HW Oncotarget; 2015 Sep; 6(26):22653-65. PubMed ID: 26093087 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]